CAMZYOS 5 mg/1
mavacamten · CAPSULE, GELATIN COATED · Myokardia, Inc.
No Recall History
Plain English
CAMZYOS is a capsule, gelatin coated containing mavacamten at 5 mg/1, taken oral. Manufactured by Myokardia, Inc..
Key Facts
- Brand Name
- CAMZYOS
- Generic Name
- mavacamten
- NDC Code (Product)
73625-112- Manufacturer
- Myokardia, Inc.
- Strength
- 5 mg/1
- Dosage Form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA214998
- Drug Class
- Cardiac Myosin Inhibitor [EPC]
- Marketing Start
- 04/28/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is CAMZYOS used for?
CAMZYOS contains mavacamten. It is a capsule, gelatin coated taken oral. Consult your doctor for specific uses.
Is CAMZYOS a controlled substance?
CAMZYOS is not classified as a controlled substance by the DEA.
What is the generic name for CAMZYOS?
The generic name for CAMZYOS is mavacamten. There are no other listed brand versions of mavacamten.
What is the NDC code for CAMZYOS 5 mg/1?
The NDC (National Drug Code) for CAMZYOS 5 mg/1 is 73625-112, listed by Myokardia, Inc..
Other CAMZYOS Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)